6 min read ·
Series A funding should finance a measurable scaling plan—not postpone the search for product-market fit. Test readiness, size the raise and compare terms.
A founder’s guide to Series A readiness, raise sizing, dilution, diligence, term-sheet trade-offs and the path from outreach to closing.

For most software companies, Series A funding is the first institutional round intended to scale a repeatable source of demand. It is commonly a priced preferred-stock financing led by a venture fund, with substantial commercial, financial and legal diligence.
“Series A” is a market label, not a legal category. US securities law does not create a separate exemption for a round because it is called seed or Series A. A company avoiding registration must fit the offering within an exemption, most commonly Regulation D. The SEC also says most venture investments are structured as equity such as preferred stock (SEC, last reviewed April 2026).
The practical question is not what the previous round was called. It is whether the company has enough evidence to support the next use of capital.
What Series A investors need to believe
A credible Series A case connects four claims:
- A defined customer has an urgent problem. The buyer, user, use case and cost of the status quo are specific.
- The product repeatedly solves it. Retention, expansion, usage depth or another relevant behavior shows that customers continue receiving value after the initial trial.
- The company has a plausible growth motion. At least one acquisition channel can be repeated without every sale depending on the founder’s personal network.
- New capital can improve a known system. Hiring, infrastructure and go-to-market spending should increase capacity or efficiency, rather than finance an open-ended search for a business model.
There is no universal revenue threshold. A self-serve developer tool, enterprise data platform and pre-revenue deep-tech company cannot be assessed on the same evidence.
| Business | Stronger readiness evidence | Misleading substitute |
|---|---|---|
| B2B SaaS | Cohort retention, expansion, sales-cycle consistency and gross margin | Annualized short pilots presented as recurring revenue |
| Developer tool | Repeated active use, team adoption, production workloads and conversion | Downloads or GitHub stars without durable use |
| Applied AI | Task frequency, output acceptance, renewal and contribution margin after inference and review | Demo quality or revenue that omits human-service costs |
| Infrastructure | Production deployments, workload growth, reliability and switching depth | Evaluations that never reach production |
| Deep tech | Technical milestones, customer validation, manufacturing path and capital plan | A prototype without evidence that performance can survive scale-up |
If the central uncertainty is still whether customers want the product, a seed extension, revenue-funded iteration or another startup funding option may fit better than a Series A process.
Size the round from milestones, not a market median
Start with the operating plan:
Raise target = forecast cash burn to the next fundable milestone + minimum cash buffer − cash on hand − conservative cash receipts
The next fundable milestone should be observable: a retention target across several cohorts, a repeatable enterprise sales motion, production deployment at a defined number of accounts, or completion of a technical and manufacturing gate. Model a base case and a downside case. The downside should include slower hiring, longer sales cycles and lower collections—not merely slightly lower revenue.
Then test the target against ownership math:
Post-money valuation = pre-money valuation + new investment
New-investor ownership = new investment ÷ post-money valuation
An $8 million investment at a $32 million pre-money valuation produces a $40 million post-money valuation and 20% headline ownership for the new money. That is not necessarily the founders’ total dilution. Converting SAFEs or notes and enlarging the employee option pool can reduce existing holders further, depending on how the term sheet defines pre-money capitalization.
Do not anchor the plan to one median. In Q1 2026, Carta reported a $300 million median Series A valuation for foundational-model AI companies on its platform, compared with $55 million for non-AI companies at the same stage. It also reported that more than 60% of venture capital raised by companies on Carta that quarter went to AI companies (Carta, May 2026). These are different segments within Carta’s dataset, not universal Series A benchmarks.
Prepare proof before outreach
A Series A data room should let an investor reproduce the important claims in the deck. Prepare:
- monthly financial statements, cash balance, burn and runway;
- a fully diluted capitalization table, including every SAFE, note, warrant and option;
- revenue reconciled to contracts and accounting records;
- customer-level cohorts, retention, expansion, churn and concentration;
- pipeline by stage, with definitions and historical conversion rates;
- product usage tied to accounts rather than aggregate activity alone;
- gross-margin detail, including cloud, inference, support and required human review;
- incorporation, board, stockholder and prior-financing records;
- employee and contractor invention-assignment agreements;
- material customer, vendor, licensing and partnership agreements; and
- security, privacy, regulatory and litigation records relevant to the product.
The deck makes the argument; the data room makes it auditable. A working pitch-deck structure can organize the story, but the model, cohorts and contracts must use the same definitions.
Also identify investors capable of leading the intended round. Check stage, sector, typical initial investment, reserves, geography, competing investments and decision process. A short list with genuine mandate fit is more useful than a long list of nominally relevant funds.
Run a concentrated process
Fundraising competes with company building, so sequence it deliberately:
- Fix the model and narrative. Define the amount, milestone plan, downside runway and non-negotiable terms.
- Prepare diligence materials. Resolve cap-table, IP and contract discrepancies before investors find them.
- Start conversations in a tight window. Comparable progress creates a real decision period and limits months of context switching.
- Track the decision path. Distinguish an interested team member from the partner who can sponsor the deal and the partnership that approves it.
- Keep operating. Send material product, customer or hiring updates, without manufacturing vanity announcements.
- Allow time after the term sheet. Legal diligence, definitive documents, signatures and funds transfer remain after a verbal agreement.
Compare the whole term sheet
Valuation matters, but it is only one economic and control variable.
- Liquidation preference: who is paid first in a sale, at what multiple, and whether preferred holders also participate in remaining proceeds.
- Board composition: who controls seats, how vacancies are filled and how any independent director is selected.
- Protective provisions: which financings, sales, debt or other actions require preferred-holder approval.
- Anti-dilution: how conversion terms adjust after a lower-priced future financing.
- Option-pool treatment: the pool size and whether an increase is counted before or after the financing.
- Pro rata rights: which investors may maintain ownership in later rounds.
- Tranches: whether all committed cash closes immediately or later funding depends on time or performance conditions.
- Founder and employee terms: vesting changes, restrictions, retention grants and any secondary liquidity.
- Information and inspection rights: what must be reported, to whom and how often.
Model at least three exit outcomes: a low-value sale, a solid exit and a large exit. Then model the next financing, including a flat or down round. A higher headline valuation can be inferior when paired with a large pre-money option-pool increase, participating preference, difficult governance or a tranche dependent on a milestone outside the company’s control.
The NVCA’s model documents are a useful US venture-financing starting point, not a substitute for company counsel. In October 2025, the association updated five models and added mechanics for financings in which later funding is triggered by time or milestones (NVCA).
Series A readiness is a capital-allocation test: the company should be able to show what works, identify the current constraint and explain how a specific amount of capital will change it before the next financing decision.